nach oben

Clinical Rheumatology

Erschienen in:

02.08.2022 | Original Article

Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram

verfasst von: Naidan Zhang, Jiaxiang Sun, Chaixia Ji, Xiao Bao, Chenliang Yuan

Erschienen in: Clinical Rheumatology | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this study was to develop and assess a risk nomogram of bacterial infection in patients with ANCA-associated vasculitis (AAV) in southwest China.

Method

We established a prediction model based on a training dataset of 249 AAV patients. The least absolute shrinkage and selection operator (Lasso) was used to screen feature variables. Multivariate logistic regression analysis was used to build a prediction model for feature variables. Nomogram was used to predict the risk of bacterial infection in AAV patients. Receiver operating characteristic (ROC) curve was used to evaluate and verify the prediction accuracy of the model. Calibration and clinical useful range was assessed using calibration curve and decision curve analysis, respectively.

Results

Bactericidal permeability enhancement protein of ANCAs (BPI-ANCAs), procalcitonin (PCT), and white blood cell (WBC) were the characteristic variables in this study. Nomogram showed that positive BPI-ANCAs and PCT had higher positive predictive value for bacterial infection in AAV patients. The area under curve (AUC) of the model was 0.703 (95% confidence interval: 0.640–0.766). In the validation model, the AUC was 0.745 (95% confidence interval: 0.617–0.872). Decision curve analysis showed that the nonadherence nomogram was clinically useful within the threshold probability range of 0.31–0.85.

Conclusions

Nomogram combined with BPI-ANCAs and PCT has the guiding significance for predicting bacterial infection risk in AAV. As an ANCA-specific autoantibody, BPI-ANCAs is helpful for clinicians to understand the role of specific autoantibodies in the pathogenesis of AAV.

Key Points

• BPI-ANCAs, PCT, and WBC could predict bacterial infection in AAV patients.

• Nomogram showed that positive BPI-ANCAs had a high positive predictive value for bacterial infection in AAV patients.

Deng X, Gao J, Zhao F (2022) Identification of differentially expressed genes and pathways in kidney of ANCA-associated vasculitis by integrated bioinformatics analysis. Ren Fail 44(1):204–216. https://doi.org/10.1080/0886022X.2022.2030755CrossRefPubMedPubMedCentral

Thery-Casari C, Euvrard R, Mainbourg S, Durupt S, Reynaud Q, Durieu I, Belot A, Lobbes H, Cabrera N, Lega JC (2020) Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: a meta-analysis. Autoimmun Rev 19(5):102505. https://doi.org/10.1016/j.autrev.2020.102505CrossRefPubMed

Hirano K, Tokui T, Inagaki M, Fujii T, Maze Y, Toyoshima H (2017) Aggregatibacter aphrophilus infective endocarditis confirmed by broad-range PCR diagnosis: a case report. Int J Surg Case Rep 31:150–153. https://doi.org/10.1016/j.ijscr.2017.01.041CrossRefPubMedPubMedCentral

Garcia-Vives E, Segarra-Medrano A, Martinez-Valle F, Agraz I, Solans-Laque R (2020) Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome. J Rheumatol 47(3):407–414. https://doi.org/10.3899/jrheum.190065CrossRefPubMed

Mosakowska M, Kania DB, Szamotulska K, Rymarz A, Niemczyk S (2021) Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies. BMC Nephrol 22(1):290. https://doi.org/10.1186/s12882-021-02495-8CrossRefPubMedPubMedCentral

Willeke P, Kumpers P, Schluter B, Limani A, Becker H, Schotte H (2015) Platelet counts as a biomarker in ANCA-associated vasculitis. Scand J Rheumatol 44(4):302–308. https://doi.org/10.3109/03009742.2015.1006247CrossRefPubMed

Herrmann K, Schinke S, Csernok E, Moosig F, Holle JU (2015) Diagnostic value of procalcitonin in ANCA-associated vasculitis (AAV) to differentiate between disease activity, infection and drug hypersensitivity. Open Rheumatol J 9:71–76. https://doi.org/10.2174/1874312901409010071CrossRefPubMedPubMedCentral

Sunderkotter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC (2018) Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol 70(2):171–184. https://doi.org/10.1002/art.40375CrossRefPubMed

Walsh M, Merkel PA, Peh CA, Szpirt WM, Puechal X, Fujimoto S, Hawley CM, Khalidi N, Flossmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suarez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW, Investigators P (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382(7):622–631. https://doi.org/10.1056/NEJMoa1803537CrossRefPubMedPubMedCentral

10.

El Sharouni MA, Ahmed T, Varey AHR, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KPM, van Diest PJ, Scolyer RA, van Gils CH, Thompson JF, Blokx WAM, Lo SN (2021) Development and validation of nomograms to predict local, regional, and distant recurrence in patients with thin (T1) melanomas. J Clin Oncol 39(11):1243–1252. https://doi.org/10.1200/JCO.20.02446CrossRefPubMed

11.

Gafita A, Calais J, Grogan TR, Hadaschik B, Wang H, Weber M, Sandhu S, Kratochwil C, Esfandiari R, Tauber R, Zeldin A, Rathke H, Armstrong WR, Robertson A, Thin P, D’Alessandria C, Rettig MB, Delpassand ES, Haberkorn U, Elashoff D, Herrmann K, Czernin J, Hofman MS, Fendler WP, Eiber M (2021) Nomograms to predict outcomes after (177)Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study. Lancet Oncol 22(8):1115–1125. https://doi.org/10.1016/S1470-2045(21)00274-6CrossRefPubMed

12.

Yang L, Xia L, Wang Y, He S, Chen H, Liang S, Peng P, Hong S, Chen Y (2017) Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma. BMC Cancer 17(1):628. https://doi.org/10.1186/s12885-017-3630-9CrossRefPubMedPubMedCentral

13.

Rathmann J, Jayne D, Segelmark M, Jonsson G, Mohammad AJ (2021) Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study. Rheumatology (Oxford) 60(6):2745–2754. https://doi.org/10.1093/rheumatology/keaa699CrossRef

14.

Sarica SH, Dhaun N, Sznajd J, Harvie J, McLaren J, McGeoch L, Kumar V, Amft N, Erwig L, Marks A, Black C, Basu N (2020) Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, matched-cohort data linkage study. Rheumatology (Oxford) 59(10):3014–3022. https://doi.org/10.1093/rheumatology/keaa070CrossRef

15.

Houben E, Bax WA, van Dam B, Slieker WAT, Verhave G, Frerichs FCP, van Eijk IC, Boersma WG, de Kuyper GTM, Penne EL (2016) Diagnosing ANCA-associated vasculitis in ANCA positive patients: a retrospective analysis on the role of clinical symptoms and the ANCA titre. Medicine (Baltimore) 95(40):e5096. https://doi.org/10.1097/MD.0000000000005096CrossRef

16.

Dunogue B, Pagnoux C, Guillevin L (2011) Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment. Semin Respir Crit Care Med 32(3):298–309. https://doi.org/10.1055/s-0031-1279826CrossRefPubMed

17.

Ledo N, Petho AG (2021) Gastrointestinal symptoms as first remarkable signs of ANCA-associated granulomatosis with polyangiitis: a case report and reviews. BMC Gastroenterol 21(1):158. https://doi.org/10.1186/s12876-021-01730-8CrossRefPubMedPubMedCentral

18.

Zhang N, Sun J, Ji C, Zhou Y, Bao X, Yuan C (2020) Clinical significance and influencing factors of fibrinogen in ANCA-associated vasculitis: a single-center retrospective study from Southwest China. Medicine (Baltimore) 99(39):e22424. https://doi.org/10.1097/MD.0000000000022424CrossRef

19.

Schultz H, Weiss JP (2007) The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 384(1–2):12–23. https://doi.org/10.1016/j.cca.2007.07.005CrossRefPubMedPubMedCentral

20.

Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A (2006) Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect Immun 74(8):4708–4714. https://doi.org/10.1128/IAI.02066-05CrossRefPubMedPubMedCentral

21.

Hovold G, Lindberg U, Ljungberg JK, Shannon O, Pahlman LI (2020) BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization. Respir Med 170:105994. https://doi.org/10.1016/j.rmed.2020.105994CrossRefPubMed

22.

Skopelja S, Hamilton BJ, Jones JD, Yang ML, Mamula M, Ashare A, Gifford AH, Rigby WF (2016) The role for neutrophil extracellular traps in cystic fibrosis autoimmunity. JCI Insight 1(17):e88912. https://doi.org/10.1172/jci.insight.88912CrossRefPubMedPubMedCentral

23.

Schultz H (2007) From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev 6(4):223–227. https://doi.org/10.1016/j.autrev.2006.08.005CrossRefPubMed

24.

Schultz H, Schinke S, Mosler K, Herlyn K, Schuster A, Gross WL (2004) BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro. Pediatr Pulmonol 37(2):158–164 https://doi.org/10.1002/ppul.10416

25.

Schultz H, Csernok E, Schuster A, Schmitz TS, Ernst M, Gross WL (2000) Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI. Pediatr Allergy Immunol 11(2):64–70. https://doi.org/10.1034/j.1399-3038.2000.00069.xCrossRefPubMed

26.

Aebi C, Theiler F, Aebischer CC, Schoeni MH (2000) Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization. Pediatr Infect Dis J 19(3):207–212. https://doi.org/10.1097/00006454-200003000-00006CrossRefPubMed

27.

Komatsuda A, Omokawa A, Fujiwara T, Sato R, Togashi M, Okuyama S, Sawada KI, Wakui H (2012) Serum procalcitonin levels in patients with myeloperoxidase-antineutrophil cytoplasmic antibodies-associated glomerulonephritis. Am J Med Sci 343(2):136–140. https://doi.org/10.1097/MAJ.0b013e31822846dbCrossRefPubMed

28.

Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P (2013) High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. J Hepatol 59(3):457–466. https://doi.org/10.1016/j.jhep.2013.04.018CrossRefPubMed

29.

Zycinska K, Wardyn KA, Zielonka TM, Tyszko P, Straburzynski M (2008) Procalcitonin as an indicator of systemic response to infection in active pulmonary Wegener’s granulomacytosis. J Physiol Pharmacol 59(Suppl 6):839–844PubMed

30.

Brunkhorst R, Eberhardt OK, Haubitz M, Brunkhorst FM (2000) Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med 26(Suppl 2):S199-201. https://doi.org/10.1007/BF02900738CrossRefPubMed

31.

Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, Piette JC, Aumaitre O (2003) Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 62(4):337–340. https://doi.org/10.1136/ard.62.4.337CrossRefPubMedPubMedCentral

32.

Clementi A, Brocca A, Virzi GM, de Cal M, Giavarina D, Carta M, Mucino-Bermejo MJ, Hinna Danesi T, Salvador L, Ronco C (2017) Procalcitonin and interleukin-6 levels: are they useful biomarkers in cardiac surgery patients? Blood Purif 43(4):290–297. https://doi.org/10.1159/000454672CrossRefPubMed

33.

Zheng W, Liang X, Shui L, Ye B, Lou G, Liu Y, Zheng M (2018) Serum procalcitonin correlates with renal function in hepatitis b virus-related acute-on-chronic liver failure. Cell Physiol Biochem 50(5):1794–1803. https://doi.org/10.1159/000494820CrossRefPubMed

34.

Quan X, Feng C, He J, Li F, Liao M, Wen J, Wang X, Hou Y, Yang H, Wei L (2021) Serum procalcitonin correlates with renal function and immune components in early-stage renal transplant recipients. Transplant Proc 53(3):927–932. https://doi.org/10.1016/j.transproceed.2021.01.032CrossRefPubMed

35.

Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R (1997) Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40(7):1250–1256. https://doi.org/10.1002/1529-0131CrossRefPubMed

36.

Xu HG, Tian M, Pan SY (2022) Clinical utility of procalcitonin and its association with pathogenic microorganisms. Crit Rev Clin Lab Sci 59(2):93–111. https://doi.org/10.1080/10408363.2021.1988047CrossRefPubMed

37.

Cheng Y, Wang TY, Yuan HL, Li W, Shen JP, He ZX, Chen J, Gao JY, Wang FK, Gu J (2021) Nocardia infection in nephrotic syndrome patients: three case studies and a systematic literature review. Front Cell Infect Microbiol 11:789754. https://doi.org/10.3389/fcimb.2021.789754CrossRefPubMed

38.

Hu T, Wang M, Chen W, Zhao J, Xiong J (2020) The clinical characteristic and outcome of skin and soft tissue infection in immunosuppressive patients with nephrotic syndrome. Clin Exp Nephrol 24(9):779–788. https://doi.org/10.1007/s10157-020-01893-wCrossRefPubMed

39.

Shi XD, Li WY, Shao X, Qu LM, Jiang ZY (2020) Infective endocarditis mimicking ANCA-associated vasculitis: does it require immunosuppressive therapy?: a case report and literature review. Medicine (Baltimore) 99(29):e21358. https://doi.org/10.1097/MD.0000000000021358CrossRef

40.

Varnier GC, Sebire N, Christov G, Eleftheriou D, Brogan PA (2016) Granulomatosis with polyangiitis mimicking infective endocarditis in an adolescent male. Clin Rheumatol 35(9):2369–2372. https://doi.org/10.1007/s10067-016-3337-3CrossRefPubMed

41.

Penafiel-Sam J, Alarcon-Guevara S, Chang-Cabanillas S, Perez-Medina W, Mendo-Urbina F, Ordaya-Espinoza E (2017) Infective endocarditis due to Bartonella bacilliformis associated with systemic vasculitis: a case report. Rev Soc Bras Med Trop 50(5):706–708. https://doi.org/10.1590/0037-8682-0042-2017CrossRefPubMed

42.

Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10(8):463–473. https://doi.org/10.1038/nrrheum.2014.103CrossRefPubMed

43.

Fukuda M, Motokawa M, Usami T, Oikawa T, Morozumi K, Yoshida A, Kimura G (2006) PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology. Clin Nephrol 66(3):202–209. https://doi.org/10.5414/cnp66202CrossRefPubMed

Titel: Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram
verfasst von: Naidan Zhang
Jiaxiang Sun
Chaixia Ji
Xiao Bao
Chenliang Yuan
Publikationsdatum: 02.08.2022
Verlag: Springer International Publishing
Erschienen in: Clinical Rheumatology / Ausgabe 11/2022
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-022-06314-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Method

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2022

Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters

Social networks as education strategies for indigenous patients with rheumatoid arthritis during COVID-19 pandemic. Are they useful?

Role of macrophage-associated chemokines in the assessment of initial axial spondyloarthritis

Clinical characteristics and outcomes of digital gangrene in connective tissue disorders: a longitudinal single-centre experience from Jodhpur, India

And high-quality and equitable care for all